Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT02629809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02629809
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-18
- Primary completion
- 2028-03-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.